Travere Therapeutics (TVTX) Tax Rate (2014 - 2026)

Travere Therapeutics' Tax Rate history runs 13 years deep, the most recent figure standing at 0.33% for Q1 2026.

• Quarterly Tax Rate rose 42.0% year-over-year to 0.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.85% (down 186.0% YoY) and the FY2025 annual result came in at 2.01%, down 197.0% from the prior year.
• Tax Rate was 0.33% for Q1 2026 at Travere Therapeutics, up from 4.37% in the prior quarter.
• Across five years, Tax Rate topped out at 0.33% in Q1 2026 and bottomed at 4.37% in Q4 2025.
• A 5-year average of 0.29% and a median of 0.07% in 2022 frame the typical range for Tax Rate.
• Annual changes were most pronounced in 2022 — Tax Rate surged 52 bps — and 2025, when it slumped 449 bps.
• Travere Therapeutics' Tax Rate stood at 0.07% in 2022, then declined by 4 bps to 0.08% in 2023, then surged by 255 bps to 0.12% in 2024, then tumbled by 3764 bps to 4.37% in 2025, then jumped by 107 bps to 0.33% in 2026.
• Business Quant data shows TVTX's Tax Rate at 0.33% in Q1 2026, 4.37% in Q4 2025, and 0.03% in Q3 2025.